Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-07-14

Clinical Trial Update: Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nimotuzumab with radiation therapy and cisplatin versus radiation therapy and cisplatin alone for stage IB to IVA cervical cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Carcinoma, Adenocarcinoma | Phase 2 | Status: WITHDRAWN